510 likes | 656 Views
Πόσο σίγουροι είμαστε για το όφελος της ενδαρτηρεκτομής ;. Γεώργιος Ντάιος Παθολογική Κλινική & Ομώνυμο Ερευνητικό Εργαστήριο Ιατρική Σχολή Πανεπιστημίου Θεσσαλίας. Heart Vessels Stroke Α thens , 2 7 - 0 1-201 3. Disclosures.
E N D
Πόσο σίγουροι είμαστε για το όφελος τηςενδαρτηρεκτομής; Γεώργιος Ντάιος Παθολογική Κλινική & Ομώνυμο Ερευνητικό Εργαστήριο Ιατρική Σχολή Πανεπιστημίου Θεσσαλίας Heart Vessels Stroke Αthens, 27-01-2013
Disclosures • Support to attend conferences: Bayer; Sanofi-Aventis; Pfizer; Lundbeck; Boehringer-Ingelheim;Bristol Myers Squibb; Galenica. • Honoraria: Quintiles; CHUV. • Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis. • National coordinator (Greece) for the ENOS trial.
ACAS: Asymptomatic Carotid Artery Study 5.1% 11% JAMA 1995; 273:1421-1428
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
It is reasonable to perform carotid endarterectomy in asymptomatic patients with >70% internal carotid artery stenosis if the risk of perioperative stroke, MI, and death is low. (Level A, Class IIb) Stroke 2011; 42(8):e464-540
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
Number-Needed-to-Treat: 40 (to prevent 1 stroke in 5 years)
Best (???) medical treatment
CAPRIE: Clopidogrel vs. Aspirin Lancet 1996; 348: 1329–39
ESPRIT: Aggrenox vs. Aspirin Lancet 2006; 367: 1665–73
Best (???) medical treatment - Better antiplateletsare available now
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
Best (???) medical treatment - Better antiplatelets are available now - 30% did not receive statin
ACAS: Asymptomatic Carotid Artery Study • Excellent safety record • an annual minimum of 12 carotidendarterectomies • mortality/morbidity rate <3% in the last 50 cases. • 40% of initial applicants were rejected • 2 strokes/deaths temporarily suspended
ACST: Asymptomatic Carotid Surgery Trial Lancet 2004; 363: 1491–502
Degree of stenosis Stroke 2000; 31:615-621
Plaque surface Stroke 2000; 31:615-621
Total plaque area Stroke 2011; 42:972-978
Intraplaquehemorrhage Radiology 2009; 252: 502-8
Microembolicsignals Lancet Neurol 2010; 9: 663–71
Microembolicsignals Lancet Neurol 2010; 9: 663–71
Silent strokes J VascSurg 2009;49:902-9
Silent strokes J VascSurg 2009;49:902-9
Risk stratification • Degree of stenosis • Plaque surface • Total plaque area • Fibrous cap • Intraplaque hemorrhage • Microemboli • Silent strokes